Pacific Edge Limited (PFGTF PINK) stock market data APIs
$0.0626
0(0%)
as of June 30, 2025
Try our APIs with
free plan!
Pacific Edge Limited Financial Data Overview
Price chart is built with
Anychart
Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up for patients with haematuria who have a low probability of bladder cancer; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a low risk of recurrence. In addition, the company is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Prev. Close
0.0626
Open
0.0626
High
0.0626
Low
0.0626
52 wk Range
0.0314-0.1231
Market Cap
64 953 K
Shares Outstanding
812 M
Revenue
22 749 K
EPS
-0.0041
Beta
0.694
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pacific Edge Limited data using free add-ons & libraries
Get Pacific Edge Limited Fundamental Data
Pacific Edge Limited Fundamental data includes:
- Net Revenue: 22 749 K
- EBITDA: -30 931 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-09-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pacific Edge Limited News
New
Recent 40% pullback isn't enough to hurt long-term Pacific Edge (NZSE:PEB) shareholders, they're still up 107% over 3 years
Some Pacific Edge Limited (NZSE:PEB) shareholders are probably rather concerned to see the share price fall 45% over the last three months. But don't let that distract from the very nice return genera...
What You Need To Know About Pacific Edge Limited's (NZSE:PEB) Investor Composition
Every investor in Pacific Edge Limited (NZSE:PEB) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning...
We're Not Worried About Pacific Edge's (NZSE:PEB) Cash Burn
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after lis...
A Pacific Edge Limited (NZSE:PEB) insider increased their holdings by 20% last year
From what we can see, insiders were net buyers in Pacific Edge Limited's (NZSE:PEB ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it. While we wou...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
